Potential of long non‐coding RNAs in cancer patients: From biomarkers to therapeutic targets

Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non‐coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a biomarker in the diagnosis and prognosis of bladder cancer...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:International journal of cancer Ročník 140; číslo 9; s. 1955 - 1967
Hlavní autori: Chandra Gupta, Subash, Nandan Tripathi, Yashoda
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Wiley Subscription Services, Inc 01.05.2017
Predmet:
Antigens, Neoplasm - genetics
biomarker
Biomarkers
Biomarkers, Tumor - genetics
Cancer
diagnosis
Gene Expression Regulation, Neoplastic
Genes
Humans
long non‐coding RNA
Medical research
Neoplasms - diagnosis
Neoplasms - genetics
Neoplasms - pathology
Polymorphism, Single Nucleotide
Prognosis
Prostate cancer
Rana
Risk Factors
RNA, Long Noncoding - genetics
therapy
diagnosis
long non-coding RNA
biomarker
prognosis
therapy
ISSN:0020-7136, 1097-0215, 1097-0215
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non‐coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a biomarker in the diagnosis and prognosis of bladder cancer, prostate cancer, gastric cancer, pancreatic cancer, breast cancer and many other cancer types. Some lncRNAs have also been used as adjunct to improve the specificity and sensitivity of existing biomarkers. The molecular tools such as RNA‐seq, RNA‐FISH, ic‐SHAPE and quantitative real‐time PCR have been used for examining the lncRNAs' potential. Some lncRNAs such as PCA3 is now routinely used in the clinic for the diagnosis of prostate cancer. Single nucleotide polymorphisms (SNPs) in lncRNAs can also be used as a predictor of cancer risk. Although ongoing studies continue to unravel the underlying mechanism, some lncRNAs have been used as therapeutic targets for the selective killing of cancer cells in patients. Thus lncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target. Companies such as the Curna Inc., MiNA Therapeutics Ltd. and RaNA Therapeutics Inc. have been taking steps to develop lncRNA based strategies against cancer. In this review, we discuss the potential of lncRNAs as biomarkers and therapeutic targets in cancer patients.
AbstractList Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non-coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a biomarker in the diagnosis and prognosis of bladder cancer, prostate cancer, gastric cancer, pancreatic cancer, breast cancer and many other cancer types. Some lncRNAs have also been used as adjunct to improve the specificity and sensitivity of existing biomarkers. The molecular tools such as RNA-seq, RNA-FISH, ic-SHAPE and quantitative real-time PCR have been used for examining the lncRNAs' potential. Some lncRNAs such as PCA3 is now routinely used in the clinic for the diagnosis of prostate cancer. Single nucleotide polymorphisms (SNPs) in lncRNAs can also be used as a predictor of cancer risk. Although ongoing studies continue to unravel the underlying mechanism, some lncRNAs have been used as therapeutic targets for the selective killing of cancer cells in patients. Thus lncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target. Companies such as the Curna Inc., MiNA Therapeutics Ltd. and RaNA Therapeutics Inc. have been taking steps to develop lncRNA based strategies against cancer. In this review, we discuss the potential of lncRNAs as biomarkers and therapeutic targets in cancer patients.Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non-coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a biomarker in the diagnosis and prognosis of bladder cancer, prostate cancer, gastric cancer, pancreatic cancer, breast cancer and many other cancer types. Some lncRNAs have also been used as adjunct to improve the specificity and sensitivity of existing biomarkers. The molecular tools such as RNA-seq, RNA-FISH, ic-SHAPE and quantitative real-time PCR have been used for examining the lncRNAs' potential. Some lncRNAs such as PCA3 is now routinely used in the clinic for the diagnosis of prostate cancer. Single nucleotide polymorphisms (SNPs) in lncRNAs can also be used as a predictor of cancer risk. Although ongoing studies continue to unravel the underlying mechanism, some lncRNAs have been used as therapeutic targets for the selective killing of cancer cells in patients. Thus lncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target. Companies such as the Curna Inc., MiNA Therapeutics Ltd. and RaNA Therapeutics Inc. have been taking steps to develop lncRNA based strategies against cancer. In this review, we discuss the potential of lncRNAs as biomarkers and therapeutic targets in cancer patients.
Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non‐coding RNAs (lncRNAs) in cancer patients continues to increase. LncRNAs have shown potential as a biomarker in the diagnosis and prognosis of bladder cancer, prostate cancer, gastric cancer, pancreatic cancer, breast cancer and many other cancer types. Some lncRNAs have also been used as adjunct to improve the specificity and sensitivity of existing biomarkers. The molecular tools such as RNA‐seq, RNA‐FISH, ic‐SHAPE and quantitative real‐time PCR have been used for examining the lncRNAs' potential. Some lncRNAs such as PCA3 is now routinely used in the clinic for the diagnosis of prostate cancer. Single nucleotide polymorphisms (SNPs) in lncRNAs can also be used as a predictor of cancer risk. Although ongoing studies continue to unravel the underlying mechanism, some lncRNAs have been used as therapeutic targets for the selective killing of cancer cells in patients. Thus lncRNAs are emerging as convenient and minimally invasive diagnostic/prognostic markers, and also as therapeutic target. Companies such as the Curna Inc., MiNA Therapeutics Ltd. and RaNA Therapeutics Inc. have been taking steps to develop lncRNA based strategies against cancer. In this review, we discuss the potential of lncRNAs as biomarkers and therapeutic targets in cancer patients.
Author Chandra Gupta, Subash
Nandan Tripathi, Yashoda
Author_xml – sequence: 1
  givenname: Subash
  surname: Chandra Gupta
  fullname: Chandra Gupta, Subash
  email: sgupta@bhu.ac.in, subhashg167@gmail.com
  organization: Department of Biochemistry, Institute of Science, Banaras Hindu University
– sequence: 2
  givenname: Yashoda
  surname: Nandan Tripathi
  fullname: Nandan Tripathi, Yashoda
  organization: Department of Biochemistry, Institute of Science, Banaras Hindu University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27925173$$D View this record in MEDLINE/PubMed
BookMark eNqN0cFu1DAQBmALtaLbwoEXQJa40EPaGcexE27VikKrChCCK5Hj2MVL1l5sR6i3PgLP2CepyxYOlUCcLMvfjDX_7JMdH7wh5BnCEQKwY7fSRzU0XDwiC4ROVsCw2SGL8gaVxFrskf2UVgCIDfDHZI_JjjUo6wX58iFk47NTEw2WTsFf0tL85vqnDqMrl4_vThJ1nmrltYl0o7IrPL2ipzGs6eDCWsVvJiaaA81fTVQbM2enaVbx0uT0hOxaNSXz9P48IJ9PX39avq0u3r85W55cVJq3UlRjZ1tkAwPRcKPlyGurpDXAWMu5BakEH6xlRo-yQY2AjdDI6oE30ClUXX1AXm77bmL4PpuU-7VL2kyT8ibMqce2RSmwA_wPyoVkDDtZ6IsHdBXm6MsgRUkha2y7u7-f36t5WJux30RXQrnqf4dcwOEW6BhSisb-IQj93QL7ssD-1wKLPX5gtcsl9OBzVG76V8UPN5mrv7fuz86X24pbmL-qrQ
CitedBy_id crossref_primary_10_1016_j_canlet_2017_12_016
crossref_primary_10_1186_s12920_020_00834_6
crossref_primary_10_3389_fonc_2020_607593
crossref_primary_10_1186_s12967_021_03026_7
crossref_primary_10_3390_cancers13235944
crossref_primary_10_2147_IDR_S540446
crossref_primary_10_1186_s13046_019_1388_4
crossref_primary_10_2147_IJGM_S341034
crossref_primary_10_1016_j_biopha_2021_111429
crossref_primary_10_3390_vaccines10071161
crossref_primary_10_7717_peerj_10225
crossref_primary_10_1016_j_etap_2021_103627
crossref_primary_10_3389_fendo_2023_1156494
crossref_primary_10_3892_ol_2018_7815
crossref_primary_10_1038_s41598_024_78255_z
crossref_primary_10_3390_ijms221910465
crossref_primary_10_1155_2022_3858249
crossref_primary_10_3389_fimmu_2022_897754
crossref_primary_10_3389_fmed_2021_651600
crossref_primary_10_1007_s11010_024_04933_1
crossref_primary_10_1016_j_cca_2023_117305
crossref_primary_10_1186_s13046_021_01943_5
crossref_primary_10_1002_jcla_24018
crossref_primary_10_1089_cbr_2019_2991
crossref_primary_10_3389_fmolb_2022_941653
crossref_primary_10_1016_j_bbcan_2019_188316
crossref_primary_10_3389_fimmu_2022_880769
crossref_primary_10_1002_jcp_29285
crossref_primary_10_3390_ncrna5010002
crossref_primary_10_1186_s12935_020_01371_z
crossref_primary_10_3748_wjg_v24_i26_2818
crossref_primary_10_1016_j_prp_2023_154774
crossref_primary_10_3389_fgene_2022_1023615
crossref_primary_10_1016_j_abb_2020_108469
crossref_primary_10_1038_s43018_021_00196_7
crossref_primary_10_12677_jcpm_2025_45453
crossref_primary_10_1007_s11845_025_04011_5
crossref_primary_10_3390_ijms241612579
crossref_primary_10_1016_j_omto_2021_04_002
crossref_primary_10_1186_s12935_020_01569_1
crossref_primary_10_3389_fonc_2022_833763
crossref_primary_10_1016_j_cca_2017_12_009
crossref_primary_10_2147_OTT_S255195
crossref_primary_10_1038_s41417_022_00487_w
crossref_primary_10_3390_cells11152448
crossref_primary_10_3390_biom12050652
crossref_primary_10_1038_s12276_024_01307_x
crossref_primary_10_2147_CMAR_S254064
crossref_primary_10_1177_15330338241290029
crossref_primary_10_3389_fmolb_2022_942636
crossref_primary_10_1007_s00018_019_03053_0
crossref_primary_10_1016_j_cellsig_2025_111736
crossref_primary_10_1038_s41598_019_47165_w
crossref_primary_10_1002_1878_0261_12446
crossref_primary_10_1016_j_elecom_2021_106929
crossref_primary_10_3389_fonc_2022_900203
crossref_primary_10_1007_s10142_023_01123_y
crossref_primary_10_1016_j_biopha_2017_12_104
crossref_primary_10_1038_s41598_017_11066_7
crossref_primary_10_1186_s12943_018_0841_x
crossref_primary_10_1186_s12885_020_07149_w
crossref_primary_10_1016_j_bbcan_2021_188502
crossref_primary_10_1186_s11658_023_00447_8
crossref_primary_10_1016_j_jid_2019_12_030
crossref_primary_10_1038_s41419_019_1845_1
crossref_primary_10_1186_s12943_022_01539_3
crossref_primary_10_1007_s10495_018_1453_z
crossref_primary_10_3892_etm_2021_10294
crossref_primary_10_1016_j_prp_2021_153475
crossref_primary_10_2147_IJGM_S327555
crossref_primary_10_1186_s40364_022_00411_2
crossref_primary_10_1089_cbr_2019_3506
crossref_primary_10_3390_cancers13081976
crossref_primary_10_1007_s11306_023_01972_5
crossref_primary_10_1016_j_clbc_2021_05_003
crossref_primary_10_1155_2020_7656031
crossref_primary_10_1186_s12885_022_09462_y
crossref_primary_10_1002_jbt_22878
crossref_primary_10_1177_03915603251314995
crossref_primary_10_1177_1010428317717670
crossref_primary_10_1002_jcp_29023
crossref_primary_10_1007_s00210_024_03564_z
crossref_primary_10_1016_j_biopha_2019_109023
crossref_primary_10_3389_fcell_2021_726716
crossref_primary_10_1186_s13046_018_0803_6
crossref_primary_10_1016_j_dci_2025_105327
crossref_primary_10_1111_cas_13951
crossref_primary_10_1016_j_prp_2024_155223
crossref_primary_10_1016_j_cca_2019_12_028
crossref_primary_10_12677_WJCR_2023_132013
crossref_primary_10_3389_fgene_2022_933009
crossref_primary_10_1016_j_lfs_2018_12_024
crossref_primary_10_3390_genes11121505
crossref_primary_10_3389_fonc_2025_1578927
crossref_primary_10_1016_j_ymthe_2023_09_015
crossref_primary_10_3892_ol_2019_10487
crossref_primary_10_1111_jcmm_14627
crossref_primary_10_7717_peerj_11599
crossref_primary_10_1590_1806_9282_20210822
crossref_primary_10_1002_jcp_30463
crossref_primary_10_3389_fonc_2024_1451009
crossref_primary_10_1080_14737159_2023_2277521
crossref_primary_10_2147_OTT_S285536
crossref_primary_10_1177_09603271211038744
crossref_primary_10_1515_med_2020_0142
crossref_primary_10_1155_2021_6664519
crossref_primary_10_1002_hed_25136
crossref_primary_10_1002_cam4_3270
crossref_primary_10_1002_cbf_3993
crossref_primary_10_1016_j_prp_2024_155708
crossref_primary_10_1186_s12890_020_01180_0
crossref_primary_10_3390_cancers14102348
crossref_primary_10_3892_ol_2018_9080
crossref_primary_10_1093_carcin_bgz125
crossref_primary_10_3389_fcell_2021_770451
crossref_primary_10_3390_cancers11111638
crossref_primary_10_1002_cam4_5905
crossref_primary_10_1186_s40659_019_0240_9
crossref_primary_10_1016_j_diff_2022_10_003
crossref_primary_10_1002_jcp_27861
crossref_primary_10_1002_jcp_28037
crossref_primary_10_1007_s00432_017_2411_9
crossref_primary_10_1016_j_prp_2020_153268
crossref_primary_10_1002_jcb_28951
crossref_primary_10_1042_BSR20210284
crossref_primary_10_3389_fonc_2019_00787
crossref_primary_10_1038_s41598_024_83154_4
crossref_primary_10_3389_fgene_2020_00413
crossref_primary_10_1080_15384101_2021_1958503
crossref_primary_10_1002_jgm_3179
crossref_primary_10_1016_j_semcancer_2018_01_007
crossref_primary_10_3389_fonc_2019_00669
crossref_primary_10_3389_fgene_2022_965033
crossref_primary_10_3389_fgene_2022_970619
crossref_primary_10_1038_s41598_019_52971_3
crossref_primary_10_3389_fphar_2024_1442227
crossref_primary_10_3390_genes13010152
crossref_primary_10_1186_s12886_022_02368_0
crossref_primary_10_1038_s41598_017_17146_y
crossref_primary_10_1016_j_cellsig_2024_111181
crossref_primary_10_1097_MD_0000000000030817
crossref_primary_10_1016_j_bbagen_2018_08_016
crossref_primary_10_1111_jcmm_13750
crossref_primary_10_3892_mmr_2018_9597
crossref_primary_10_3390_biom14040384
crossref_primary_10_1016_j_procbio_2022_09_021
crossref_primary_10_1002_jgm_3287
crossref_primary_10_1186_s13062_022_00341_x
crossref_primary_10_3389_fonc_2020_598817
crossref_primary_10_3390_cancers14102369
crossref_primary_10_3892_br_2018_1116
crossref_primary_10_1007_s13402_019_00478_4
crossref_primary_10_1097_CAD_0000000000001539
crossref_primary_10_1016_j_omto_2021_07_001
crossref_primary_10_3389_fgene_2020_597795
crossref_primary_10_3390_ncrna8020021
crossref_primary_10_1016_j_prp_2019_152757
crossref_primary_10_1016_j_prp_2023_154675
crossref_primary_10_3892_ijmm_2023_5282
crossref_primary_10_3892_mmr_2019_10615
crossref_primary_10_1016_j_prp_2023_154679
crossref_primary_10_1089_dna_2017_3805
crossref_primary_10_4103_ATN_ATN_D_24_00030
crossref_primary_10_1186_s12890_021_01552_0
crossref_primary_10_1111_cas_13879
crossref_primary_10_1080_08923973_2022_2056482
crossref_primary_10_3389_fgene_2021_625019
crossref_primary_10_3923_ijp_2024_552_560
crossref_primary_10_4103_jcrt_JCRT_282_19
crossref_primary_10_1093_toxres_tfad026
crossref_primary_10_1007_s00432_023_05435_1
crossref_primary_10_1016_j_prp_2023_155081
crossref_primary_10_1186_s12935_021_01921_z
crossref_primary_10_3390_ijms221810033
crossref_primary_10_3892_mmr_2019_10292
crossref_primary_10_1038_s41598_025_05486_z
crossref_primary_10_1016_j_biopha_2019_108655
crossref_primary_10_1002_jcp_26621
crossref_primary_10_3892_mmr_2018_8827
crossref_primary_10_1111_cas_15140
crossref_primary_10_2147_CMAR_S250166
crossref_primary_10_3390_genes16020140
crossref_primary_10_1186_s12920_024_02042_y
crossref_primary_10_1371_journal_pone_0265264
crossref_primary_10_3389_fgene_2018_00471
crossref_primary_10_1038_s41419_022_04865_y
crossref_primary_10_18632_oncotarget_20036
crossref_primary_10_1007_s11426_024_2189_1
crossref_primary_10_1016_j_biopha_2017_06_103
crossref_primary_10_1186_s12872_020_01522_0
crossref_primary_10_1155_2019_3076345
crossref_primary_10_3389_fgene_2020_567630
crossref_primary_10_3389_fonc_2022_876660
crossref_primary_10_1186_s12885_021_08322_5
crossref_primary_10_1038_s41419_019_1658_2
crossref_primary_10_3892_ijmm_2024_5374
crossref_primary_10_1007_s12672_025_01848_1
crossref_primary_10_1186_s13045_018_0690_5
crossref_primary_10_1007_s11060_022_04113_5
crossref_primary_10_1016_j_bbrc_2018_03_017
crossref_primary_10_1016_j_biopha_2022_113609
crossref_primary_10_3390_ijms222212491
crossref_primary_10_3892_ol_2019_11063
crossref_primary_10_3390_cancers12051246
crossref_primary_10_1007_s10616_023_00612_z
crossref_primary_10_1016_j_bbe_2020_10_005
crossref_primary_10_1186_s12935_020_1126_1
crossref_primary_10_2147_OTT_S267915
crossref_primary_10_1089_dna_2020_6103
crossref_primary_10_1002_jcp_29442
crossref_primary_10_1002_jcp_29203
crossref_primary_10_1002_jcb_28074
crossref_primary_10_1016_j_omtn_2025_102629
crossref_primary_10_3389_fgene_2022_831759
crossref_primary_10_3389_fimmu_2022_929846
crossref_primary_10_1007_s00216_019_01607_6
crossref_primary_10_1093_nar_gkz985
crossref_primary_10_3390_cells11213407
crossref_primary_10_3390_ijms18020473
crossref_primary_10_1038_s41419_021_03690_z
crossref_primary_10_3389_fonc_2024_1394292
crossref_primary_10_1080_14737159_2020_1743687
crossref_primary_10_1186_s12943_018_0829_6
crossref_primary_10_1111_1759_7714_14238
crossref_primary_10_1186_s13046_020_01725_5
crossref_primary_10_1007_s13577_021_00607_y
crossref_primary_10_3389_fonc_2023_1063636
crossref_primary_10_1016_j_biocel_2024_106552
crossref_primary_10_1007_s12672_024_00888_3
crossref_primary_10_3390_cancers13164041
crossref_primary_10_1093_bbb_zbaa049
crossref_primary_10_1186_s12957_023_03114_6
crossref_primary_10_1042_BSR20200767
crossref_primary_10_3892_ol_2019_10758
crossref_primary_10_1007_s43032_021_00571_w
crossref_primary_10_3389_fmolb_2023_1096524
crossref_primary_10_1186_s12935_024_03596_8
crossref_primary_10_1089_dna_2021_0563
crossref_primary_10_1002_cam4_5550
crossref_primary_10_3389_fphar_2017_00669
crossref_primary_10_3892_or_2021_8232
crossref_primary_10_1155_2021_1244612
crossref_primary_10_1002_pros_23700
crossref_primary_10_3389_fimmu_2021_800268
crossref_primary_10_1097_CAD_0000000000001214
crossref_primary_10_1186_s12943_019_1013_3
crossref_primary_10_3389_fped_2024_1309693
crossref_primary_10_1016_j_cca_2020_11_015
crossref_primary_10_1016_j_ijbiomac_2023_125863
crossref_primary_10_1002_jcp_29544
crossref_primary_10_1007_s12253_018_0486_5
crossref_primary_10_1016_j_cancergen_2024_12_006
crossref_primary_10_1007_s00018_024_05172_9
crossref_primary_10_3892_ijo_2017_4111
crossref_primary_10_1016_j_jmoldx_2021_07_014
crossref_primary_10_3892_ijo_2019_4813
crossref_primary_10_3892_ol_2018_9831
crossref_primary_10_1016_j_bone_2020_115617
crossref_primary_10_1038_s41417_017_0006_x
crossref_primary_10_1038_s41388_021_01839_w
crossref_primary_10_1042_BSR20211115
crossref_primary_10_1186_s13046_020_01748_y
crossref_primary_10_1016_j_bbrc_2020_05_178
crossref_primary_10_3389_fonc_2023_1134456
crossref_primary_10_1080_17520363_2025_2455925
crossref_primary_10_3390_ijms19113416
crossref_primary_10_1007_s44411_025_00219_0
crossref_primary_10_1093_carcin_bgy069
crossref_primary_10_1007_s00432_023_04700_7
crossref_primary_10_3389_fmed_2020_612393
crossref_primary_10_1016_j_tranon_2021_101134
crossref_primary_10_1038_s41375_018_0067_3
crossref_primary_10_1007_s12094_023_03246_x
crossref_primary_10_1089_hum_2023_074
crossref_primary_10_1111_iep_12350
crossref_primary_10_1186_s12885_023_10508_y
crossref_primary_10_3389_fcvm_2021_688546
crossref_primary_10_1016_j_biopha_2020_110775
crossref_primary_10_3390_ijms25031587
crossref_primary_10_1007_s12032_025_02859_2
crossref_primary_10_3390_diseases9010008
crossref_primary_10_1007_s10528_024_10770_0
crossref_primary_10_1186_s12931_025_03122_y
crossref_primary_10_1089_cbr_2019_3486
crossref_primary_10_1089_cbr_2019_3484
crossref_primary_10_1261_rna_078915_121
crossref_primary_10_1016_j_lfs_2020_118193
crossref_primary_10_3389_fgene_2022_838624
crossref_primary_10_1016_j_ncrna_2025_09_005
crossref_primary_10_1186_s13046_020_01622_x
crossref_primary_10_3390_biom12010039
crossref_primary_10_1016_j_semcancer_2017_11_009
crossref_primary_10_3390_ijms21093218
crossref_primary_10_1186_s12943_017_0737_1
crossref_primary_10_3390_cancers13050977
crossref_primary_10_1038_s41388_018_0162_y
crossref_primary_10_2147_BLCTT_S454115
crossref_primary_10_4103_NRR_NRR_D_23_01355
crossref_primary_10_1186_s12935_021_02272_5
crossref_primary_10_1002_jcla_23377
crossref_primary_10_3389_fonc_2022_904327
crossref_primary_10_1002_1878_0261_12489
crossref_primary_10_1097_SCS_0000000000007824
crossref_primary_10_1016_j_ygeno_2023_110665
crossref_primary_10_3390_ijms25158456
crossref_primary_10_3389_fmolb_2021_706570
crossref_primary_10_3390_cancers12092698
crossref_primary_10_1038_s41417_024_00734_2
crossref_primary_10_1155_2022_8093949
crossref_primary_10_1016_j_ejphar_2018_04_027
crossref_primary_10_1016_j_tig_2020_03_003
crossref_primary_10_1177_17588359221118010
crossref_primary_10_1038_s41417_021_00312_w
crossref_primary_10_1155_2021_1683129
crossref_primary_10_3390_mi11090820
crossref_primary_10_3389_fimmu_2024_1481296
crossref_primary_10_3389_fonc_2022_920926
crossref_primary_10_1007_s00018_019_03444_3
crossref_primary_10_1186_s12935_021_02013_8
crossref_primary_10_1016_j_yexcr_2020_112087
crossref_primary_10_1111_1759_7714_13310
crossref_primary_10_1111_cpr_12425
crossref_primary_10_3892_ol_2021_13063
crossref_primary_10_3233_CBM_181250
crossref_primary_10_3389_fonc_2021_630260
crossref_primary_10_1155_2022_6175053
crossref_primary_10_1002_jcp_27320
crossref_primary_10_1155_2020_9879876
crossref_primary_10_1016_j_semcancer_2020_06_019
crossref_primary_10_3389_fnmol_2022_949095
crossref_primary_10_1186_s13046_017_0666_2
crossref_primary_10_1097_MD_0000000000013429
crossref_primary_10_3390_cells8091107
crossref_primary_10_1038_s41375_021_01147_y
crossref_primary_10_1002_jcb_26479
crossref_primary_10_3390_ijms20163960
crossref_primary_10_3390_ijms21155534
crossref_primary_10_1038_s41368_022_00209_w
crossref_primary_10_1002_jcp_28765
crossref_primary_10_1016_j_cca_2022_09_013
crossref_primary_10_1016_j_gene_2021_145975
crossref_primary_10_1038_s41419_020_03273_4
crossref_primary_10_1186_s12935_021_02404_x
Cites_doi 10.1001/archotol.126.9.1079
10.18632/oncotarget.2691
10.1158/1078-0432.CCR-06-0134
10.1016/j.eururo.2013.09.046
10.1093/nar/gkm863
10.1007/s13277-014-2311-4
10.1007/s13277-014-2863-3
10.1038/nrg2521
10.1016/S0302-2838(03)00201-X
10.1038/mtna.2014.45
10.1038/cgt.2012.10
10.1371/journal.pone.0090008
10.1186/s13148-015-0141-x
10.1038/jid.2015.200
10.1038/ng.3637
10.3892/or.2014.3186
10.1089/dna.2006.25.135
10.1016/j.jmoldx.2014.06.009
10.1158/2159-8290.CD-11-0209
10.1007/s00268-010-0951-0
10.3816/CLM.2008.n.021
10.1038/pcan.2013.6
10.1038/bjc.2013.233
10.1158/1078-0432.CCR-06-2679
10.1371/journal.pone.0110059
10.1016/j.eururo.2010.06.039
10.1016/j.juro.2013.12.011
10.4149/314_150825N45
10.1016/j.molcel.2011.08.018
10.1371/journal.pgen.1003368
10.1007/s13277-014-2526-4
10.1007/s13277-014-2378-y
10.1136/mp.53.6.320
10.1002/bies.200900112
10.1038/cddis.2014.541
10.1002/mc.22215
10.1093/nar/gkt1222
10.1093/nar/gkt464
10.1038/nrd4018
10.1371/journal.pgen.1003078
10.1038/nature01266
10.1136/jclinpath-2015-203275
10.1016/j.molcel.2012.07.033
10.1016/j.eururo.2004.06.004
10.1126/science.1192002
10.1093/mutage/gew018
10.1002/pros.22949
10.1007/s13277-015-3543-7
10.1038/nature10398
10.1186/1471-2407-14-809
10.1016/j.juro.2007.11.038
10.1158/0008-5472.CAN-10-2483
10.18632/oncotarget.7828
10.1038/nature13975
10.3892/mmr.2016.4894
10.1158/0008-5472.CAN-15-3284
10.3109/10408363.2015.1075469
10.3892/or.2015.4415
10.5732/cjc.012.10219
10.1093/nar/gku1198
10.7314/APJCP.2015.16.13.5181
10.1016/j.tips.2013.06.005
10.1073/pnas.1517883113
10.1097/IGC.0000000000000413
10.1186/s13058-016-0690-8
10.1038/pcan.2014.34
10.1016/j.juro.2008.08.006
10.1002/hep.24563
10.1038/nature10887
10.1089/nat.2012.0414
10.1038/nature08975
10.1177/147323001103900608
10.1126/science.1247005
10.1373/clinchem.2005.063289
10.1007/s13277-013-0821-0
10.3892/mmr.2015.4435
10.1038/nchembio.1551
10.1073/pnas.0904715106
10.1038/ni.3299
10.18632/oncotarget.3287
10.1371/journal.pone.0108237
10.1002/hep.27239
10.1007/s13277-016-4863-y
10.1186/1471-2490-12-37
10.1186/1479-5876-7-69
10.3892/mmr.2012.1254
10.1016/j.juro.2009.01.110
10.1186/1476-4598-13-156
10.1016/j.cell.2013.04.025
10.1016/j.molcel.2012.06.027
10.1056/NEJMoa1405760
10.1016/j.gene.2006.09.028
10.1016/j.eururo.2008.01.060
10.1002/jso.23888
10.1016/j.biopha.2015.04.014
10.1038/nm.3981
10.1016/j.urology.2006.12.014
10.1158/1541-7786.MCR-14-0257
10.1161/CIRCULATIONAHA.114.013303
10.1007/s12032-011-0004-z
10.1016/j.trecan.2015.08.010
10.1002/cam4.220
10.3322/caac.20107
10.1016/j.bbrc.2016.01.056
10.1007/s13277-014-2474-z
10.1186/s12864-015-1881-x
10.1016/j.canlet.2014.12.051
10.1002/hep.25895
10.1038/nbt.2884
10.1245/s10434-011-1581-y
10.1002/hed.21193
10.1038/ng.848
10.1007/s13277-015-4052-4
10.1161/JAHA.114.001084
10.4161/rna.29624
10.1073/pnas.0903086106
10.1530/ERC-14-0457
10.1186/1756-9966-32-104
10.1007/s13402-011-0018-8
10.1111/apm.12480
10.1371/journal.pgen.1003569
10.1016/S1470-2045(14)71113-1
10.1093/jnci/djn180
10.1073/pnas.0903103106
10.1126/science.1246981
10.1371/journal.pone.0147236
10.1007/s13277-014-2042-6
10.1007/s13277-014-2765-4
10.1016/j.ejca.2013.04.026
10.1111/j.1349-7006.2010.01737.x
10.1002/stem.1989
10.1155/2014/404567
10.1016/j.drudis.2009.01.008
10.1093/carcin/bgr187
10.3892/ijo.2014.2758
10.1186/s12967-015-0490-4
10.1038/nature09819
10.1074/jbc.M111.326694
10.1158/1078-0432.CCR-13-0877
10.1093/bfgp/elq029
10.1007/s13277-014-2344-8
ContentType Journal Article
Copyright 2016 UICC
2016 UICC.
2017 UICC
Copyright_xml – notice: 2016 UICC
– notice: 2016 UICC.
– notice: 2017 UICC
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
7TM
DOI 10.1002/ijc.30546
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
Nucleic Acids Abstracts
DatabaseTitleList MEDLINE - Academic
CrossRef
Oncogenes and Growth Factors Abstracts
MEDLINE

AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 1967
ExternalDocumentID 4320489231
27925173
10_1002_ijc_30546
IJC30546
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Science and Engineering Research Board
  funderid: ECR/2016/000034
– fundername: University Grants Commission, and Design and Innovation Center at Banaras Hindu University (DIC‐BHU/Project Approval/2015–16/608)
GroupedDBID ---
-~X
.3N
.GA
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
.55
.GJ
.Y3
31~
3O-
53G
8WZ
A6W
AAMMB
AANHP
AAYXX
ABEFU
ABEML
ACBWZ
ACRPL
ACSCC
ACYXJ
ADNMO
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AHEFC
AI.
AIDQK
AIDYY
AIQQE
ASPBG
AVWKF
AZFZN
BDRZF
CITATION
EX3
FEDTE
GLUZI
HF~
HVGLF
M6P
O8X
PALCI
RJQFR
SAMSI
VH1
WOW
X7M
Y6R
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
7TM
ID FETCH-LOGICAL-c4876-d9f812b20654ec7d43fa7fe022844f07a64bff2ecd751c10156c123b4509a1a93
IEDL.DBID DRFUL
ISICitedReferencesCount 473
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000399313000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0020-7136
1097-0215
IngestDate Sun Nov 09 12:39:08 EST 2025
Thu Oct 02 03:35:06 EDT 2025
Sat Nov 29 14:33:35 EST 2025
Thu Apr 03 07:04:06 EDT 2025
Sat Nov 29 03:46:14 EST 2025
Tue Nov 18 22:08:18 EST 2025
Wed Jan 22 16:49:25 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords diagnosis
long non-coding RNA
biomarker
prognosis
therapy
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2016 UICC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4876-d9f812b20654ec7d43fa7fe022844f07a64bff2ecd751c10156c123b4509a1a93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.30546
PMID 27925173
PQID 1876731899
PQPubID 105430
PageCount 13
ParticipantIDs proquest_miscellaneous_1881761901
proquest_miscellaneous_1846722197
proquest_journals_1876731899
pubmed_primary_27925173
crossref_primary_10_1002_ijc_30546
crossref_citationtrail_10_1002_ijc_30546
wiley_primary_10_1002_ijc_30546_IJC30546
PublicationCentury 2000
PublicationDate 1 May 2017
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 1 May 2017
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2012; 482
2011; 477
2015; 72
2015; 75
2010; 464
2011; 61
2016; 31
2012; 19
2011; 54
2013; 7
2008; 100
2012; 12
2016; 37
2016; 35
2013; 9
2011; 472
2015; 372
2009; 14
2009; 10
2000; 126
2015; 135
2011; 71
2006; 25
2015; 131
1999; 59
2002; 420
2014; 16
2014; 15
2014; 14
2014; 13
2012; 29
2014; 17
2016; 48
2014; 12
2007; 69
2014; 11
2003; 44
2014; 10
2010; 32
2006; 52
2010; 329
2011; 1
2013; 108
2009; 181
2004; 46
2015; 54
2008; 54
2014; 2014
2016; 18
2016; 15
2007; 13
2016; 13
2014; 42
2016; 11
2016; 7
2002; 62
2015; 111
2015; 518
2014; 35
2012; 48
2015; 359
2012; 47
2014; 32
2009; 106
2012; 40
2015; 35
2015; 36
2012; 287
2010; 58
2013; 23
2007; 386
2015; 33
2016; 76
2011; 10
2008; 8
2012; 56
2014; 60
2011; 18
2007; 35
2014; 65
2013; 19
2015; 46
2014; 5
2014; 3
2013; 16
2013; 12
2000; 53
2015; 43
2016; 113
2013; 153
2014; 9
2016; 470
2015; 13
2015; 1
2015; 12
2015; 6
2015; 16
2015; 19
2013; 49
2006; 12
2013; 41
2016; 124
2016; 53
2014; 191
2011; 32
2011; 35
2011; 34
2011; 39
2015; 8
2015; 7
2008; 180
2012; 92
2015; 25
2011; 102
2013; 32
2013; 34
2015; 22
2015; 21
2016; 63
2011; 43
2016
2009; 7
2008; 179
2016; 69
2012; 8
2014; 343
e_1_2_9_98_1
e_1_2_9_79_1
e_1_2_9_94_1
e_1_2_9_10_1
e_1_2_9_56_1
e_1_2_9_33_1
Karlsson O (e_1_2_9_144_1) 2016
e_1_2_9_71_1
e_1_2_9_103_1
e_1_2_9_126_1
e_1_2_9_149_1
Kok JB (e_1_2_9_32_1) 2002; 62
e_1_2_9_107_1
e_1_2_9_122_1
e_1_2_9_145_1
e_1_2_9_14_1
e_1_2_9_141_1
e_1_2_9_37_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_87_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_83_1
e_1_2_9_6_1
e_1_2_9_60_1
e_1_2_9_2_1
e_1_2_9_138_1
e_1_2_9_111_1
e_1_2_9_134_1
e_1_2_9_115_1
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_130_1
e_1_2_9_153_1
e_1_2_9_30_1
e_1_2_9_53_1
Yang L (e_1_2_9_72_1) 2015; 19
e_1_2_9_99_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_95_1
e_1_2_9_76_1
e_1_2_9_91_1
Iguchi T (e_1_2_9_90_1) 2015; 35
e_1_2_9_102_1
e_1_2_9_148_1
e_1_2_9_129_1
e_1_2_9_106_1
e_1_2_9_125_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_140_1
e_1_2_9_121_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_88_1
e_1_2_9_61_1
e_1_2_9_46_1
e_1_2_9_84_1
e_1_2_9_23_1
Tantai J (e_1_2_9_65_1) 2015; 8
e_1_2_9_80_1
e_1_2_9_5_1
e_1_2_9_114_1
e_1_2_9_137_1
e_1_2_9_133_1
e_1_2_9_9_1
e_1_2_9_152_1
e_1_2_9_27_1
Bussemakers MJ (e_1_2_9_31_1) 1999; 59
e_1_2_9_69_1
e_1_2_9_110_1
e_1_2_9_50_1
e_1_2_9_73_1
Bennett ER (e_1_2_9_119_1) 2016
Han L (e_1_2_9_118_1) 2012; 40
e_1_2_9_35_1
e_1_2_9_77_1
e_1_2_9_96_1
e_1_2_9_12_1
e_1_2_9_92_1
e_1_2_9_109_1
Hao S (e_1_2_9_82_1) 2015; 8
e_1_2_9_101_1
e_1_2_9_128_1
e_1_2_9_105_1
e_1_2_9_124_1
e_1_2_9_147_1
e_1_2_9_39_1
Zhang Z (e_1_2_9_52_1) 2012; 92
Xu S (e_1_2_9_74_1) 2015; 8
e_1_2_9_120_1
e_1_2_9_16_1
e_1_2_9_58_1
e_1_2_9_143_1
e_1_2_9_20_1
e_1_2_9_62_1
e_1_2_9_89_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_85_1
e_1_2_9_8_1
e_1_2_9_81_1
e_1_2_9_4_1
e_1_2_9_113_1
e_1_2_9_117_1
e_1_2_9_136_1
e_1_2_9_151_1
e_1_2_9_28_1
e_1_2_9_47_1
e_1_2_9_132_1
Camargo Cancela M (e_1_2_9_54_1) 2010; 32
e_1_2_9_51_1
e_1_2_9_78_1
e_1_2_9_13_1
e_1_2_9_55_1
e_1_2_9_97_1
e_1_2_9_93_1
e_1_2_9_108_1
e_1_2_9_70_1
e_1_2_9_127_1
e_1_2_9_100_1
e_1_2_9_123_1
e_1_2_9_104_1
e_1_2_9_146_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_142_1
Wang J (e_1_2_9_75_1) 2016; 15
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_21_1
e_1_2_9_67_1
e_1_2_9_44_1
e_1_2_9_86_1
e_1_2_9_7_1
e_1_2_9_3_1
e_1_2_9_112_1
e_1_2_9_139_1
e_1_2_9_116_1
e_1_2_9_135_1
e_1_2_9_25_1
e_1_2_9_131_1
e_1_2_9_154_1
e_1_2_9_48_1
e_1_2_9_29_1
e_1_2_9_150_1
References_xml – volume: 131
  start-page: 1278
  year: 2015
  end-page: 1290
  article-title: Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development
  publication-title: Circulation
– volume: 71
  start-page: 3
  year: 2011
  end-page: 7
  article-title: Long intergenic noncoding RNAs: new links in cancer progression
  publication-title: Cancer Res
– volume: 23
  start-page: 15
  year: 2013
  end-page: 20
  article-title: Long non‐coding RNAs: challenges for diagnosis and therapies
  publication-title: Nucleic Acid Ther
– volume: 92
  start-page: 384
  year: 2012
  end-page: 387
  article-title: [Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer]
  publication-title: Zhonghua Yi Xue Za Zhi
– volume: 181
  start-page: 2508
  year: 2009
  end-page: 2513
  article-title: A duplex quantitative polymerase chain reaction assay based on quantification of alpha‐methylacyl‐CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer
  publication-title: J Urol
– volume: 179
  start-page: 1587
  year: 2008
  end-page: 1592
  article-title: PCA3: a molecular urine assay for predicting prostate biopsy outcome
  publication-title: J Urol
– volume: 8
  start-page: 7887
  year: 2015
  end-page: 7895
  article-title: Combined identification of long non‐coding RNA XIST and HIF1A‐AS1 in serum as an effective screening for non‐small cell lung cancer
  publication-title: Int J Clin Exp Pathol
– volume: 12
  start-page: 7915
  year: 2015
  end-page: 7926
  article-title: Coexpression of the carbamoylphosphate synthase 1 gene and its long noncoding RNA correlates with poor prognosis of patients with intrahepatic cholangiocarcinoma
  publication-title: Mol Med Rep
– volume: 11
  start-page: 829
  year: 2014
  end-page: 835
  article-title: Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9
  publication-title: RNA Biol
– volume: 69
  start-page: 76
  year: 2016
  end-page: 81
  article-title: Long non‐coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology
  publication-title: J Clin Pathol
– volume: 44
  start-page: 8
  year: 2003
  end-page: 15
  article-title: DD3(PCA3)‐based molecular urine analysis for the diagnosis of prostate cancer
  publication-title: Eur Urol
– volume: 46
  start-page: 182
  year: 2004
  end-page: 186
  article-title: DD3PCA3 RNA analysis in urine–a new perspective for detecting prostate cancer
  publication-title: Eur Urol
– volume: 13
  start-page: 156
  year: 2014
  article-title: Long non‐coding RNA HOTAIR, a c‐Myc activated driver of malignancy, negatively regulates miRNA‐130a in gallbladder cancer
  publication-title: Mol Cancer
– volume: 124
  start-page: 169
  year: 2016
  end-page: 174
  article-title: Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients
  publication-title: Apmis
– volume: 18
  start-page: 1243
  year: 2011
  end-page: 1250
  article-title: Overexpression of long non‐coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation
  publication-title: Ann Surg Oncol
– volume: 37
  start-page: 9875
  year: 2016
  end-page: 9886
  article-title: Expression and mechanisms of long non‐coding RNA genes MEG3 and ANRIL in gallbladder cancer
  publication-title: Tumour Biol
– volume: 19
  start-page: 3187
  year: 2015
  end-page: 3193
  article-title: High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 33
  start-page: 1985
  year: 2015
  end-page: 1997
  article-title: Upregulation of lncRNA MEG3 promotes osteogenic differentiation of mesenchymal stem cells from multiple myeloma patients by targeting BMP4 transcription
  publication-title: Stem Cells
– volume: 36
  start-page: 8041
  year: 2015
  end-page: 8045
  article-title: Reduced expression of the long non‐coding RNA AI364715 in gastric cancer and its clinical significance
  publication-title: Tumour Biol
– volume: 41
  start-page: e141
  year: 2013
  article-title: Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish
  publication-title: Nucleic Acids Res
– volume: 54
  start-page: 1397
  year: 2015
  end-page: 1406
  article-title: Long non‐coding RNA‐LET is a positive prognostic factor and exhibits tumor‐suppressive activity in gallbladder cancer
  publication-title: Mol Carcinog
– volume: 16
  start-page: 5181
  year: 2015
  end-page: 5185
  article-title: Aberrant expression of CCAT1 regulated by c‐Myc predicts the prognosis of hepatocellular carcinoma
  publication-title: Asian Pac J Cancer Prev
– volume: 42
  start-page: D98
  year: 2014
  end-page: 103
  article-title: NONCODEv4: exploring the world of long non‐coding RNA genes
  publication-title: Nucleic Acids Res
– volume: 343
  start-page: 80
  year: 2014
  end-page: 84
  article-title: Genetic screens in human cells using the CRISPR‐Cas9 system
  publication-title: Science
– volume: 106
  start-page: 9362
  year: 2009
  end-page: 9367
  article-title: Potential etiologic and functional implications of genome‐wide association loci for human diseases and traits
  publication-title: Proc Natl Acad Sci U S A
– volume: 35
  start-page: 7336
  year: 2007
  end-page: 7347
  article-title: Expression of a novel non‐coding mitochondrial RNA in human proliferating cells
  publication-title: Nucleic Acids Res
– volume: 111
  start-page: 834
  year: 2015
  end-page: 839
  article-title: Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma
  publication-title: J Surg Oncol
– volume: 8
  start-page: 4881
  year: 2015
  end-page: 4891
  article-title: Downregulation of long noncoding RNA MALAT1 induces epithelial‐to‐mesenchymal transition via the PI3K‐AKT pathway in breast cancer
  publication-title: Int J Clin Exp Pathol
– volume: 16
  start-page: 139
  year: 2013
  end-page: 144
  article-title: Association between lncrna PCGEM1 polymorphisms and prostate cancer risk
  publication-title: Prostate Cancer Prostatic Dis
– volume: 58
  start-page: 475
  year: 2010
  end-page: 481
  article-title: Performance of the prostate cancer antigen 3 (PCA3) gene and prostate‐specific antigen in prescreened men: exploring the value of PCA3 for a first‐line diagnostic test
  publication-title: Eur Urol
– volume: 482
  start-page: 339
  year: 2012
  end-page: 346
  article-title: Modular regulatory principles of large non‐coding RNAs
  publication-title: Nature
– volume: 5
  start-page: 11091
  year: 2014
  end-page: 11102
  article-title: Development and prospective multicenter evaluation of the long noncoding RNA MALAT‐1 as a diagnostic urinary biomarker for prostate cancer
  publication-title: Oncotarget
– volume: 126
  start-page: 1079
  year: 2000
  end-page: 1085
  article-title: Impact of comorbidity, symptoms, and patients' characteristics on the prognosis of oral carcinomas
  publication-title: Arch Otolaryngol Head Neck Surg
– volume: 35
  start-page: 8351
  year: 2014
  end-page: 8352
  article-title: Long noncoding RNA HMlincRNA717 and AC130710 have been officially named as gastric cancer associated transcript 2 (GACAT2) and GACAT3, respectively
  publication-title: Tumour Biol
– volume: 34
  start-page: 508
  year: 2013
  end-page: 517
  article-title: Cancer drug discovery by repurposing: teaching new tricks to old dogs
  publication-title: Trends Pharmacol Sci
– volume: 65
  start-page: 124
  year: 2014
  end-page: 137
  article-title: European Association of U. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent‐update 2013
  publication-title: Eur Urol
– volume: 53
  start-page: 29
  year: 2016
  end-page: 39
  article-title: Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?
  publication-title: Crit Rev Clin Lab Sci
– volume: 76
  start-page: 2105
  year: 2016
  end-page: 2114
  article-title: Transcriptome analysis of triple‐negative breast cancer reveals an integrated mRNA‐lncRNA signature with predictive and prognostic value
  publication-title: Cancer Res
– volume: 7
  start-page: 109
  year: 2015
  article-title: Analysis of the Polycomb‐related lncRNAs HOTAIR and ANRIL in bladder cancer
  publication-title: Clin Epigenetics
– volume: 62
  start-page: 2695
  year: 2002
  end-page: 2698
  article-title: DD3(PCA3), a very sensitive and specific marker to detect prostate tumors
  publication-title: Cancer Res
– volume: 14
  start-page: 809
  year: 2014
  article-title: MALAT1 long non‐coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression
  publication-title: BMC Cancer
– volume: 47
  start-page: 648
  year: 2012
  end-page: 655
  article-title: LincRNA‐p21 suppresses target mRNA translation
  publication-title: Mol Cell
– volume: 36
  start-page: 2501
  year: 2015
  end-page: 2507
  article-title: Upregulation of the long noncoding RNA PCAT‐1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma
  publication-title: Tumour Biol
– year: 2016
– volume: 54
  start-page: 1118
  year: 2008
  end-page: 1126
  article-title: Polymorphisms in the H19 gene and the risk of bladder cancer
  publication-title: Eur Urol
– volume: 386
  start-page: 1
  year: 2007
  end-page: 10
  article-title: Non‐coding RNAs: lost in translation?
  publication-title: Gene
– volume: 16
  start-page: 1282
  year: 2015
  end-page: 1291
  article-title: Long non‐coding RNA profiling of human lymphoid progenitor cells reveals transcriptional divergence of B cell and T cell lineages
  publication-title: Nat Immunol
– volume: 359
  start-page: 75
  year: 2015
  end-page: 86
  article-title: Knockdown of long non‐coding RNA XIST exerts tumor‐suppressive functions in human glioblastoma stem cells by up‐regulating miR‐152
  publication-title: Cancer Lett
– volume: 17
  start-page: 315
  year: 2014
  end-page: 319
  article-title: Polymorphisms at long non‐coding RNAs and prostate cancer risk in an eastern Chinese population
  publication-title: Prostate Cancer Prostatic Dis
– volume: 1
  start-page: 93
  year: 2015
  end-page: 109
  article-title: Long noncoding RNAs in cancer: from function to translation
  publication-title: Trends Cancer
– volume: 7
  start-page: 20584
  year: 2016
  end-page: 20596
  article-title: Long non‐coding RNAs as prognostic markers in human breast cancer
  publication-title: Oncotarget
– volume: 102
  start-page: 245
  year: 2011
  end-page: 252
  article-title: Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility
  publication-title: Cancer Sci
– volume: 3
  start-page: 632
  year: 2014
  end-page: 642
  article-title: Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small‐cell lung cancer
  publication-title: Cancer Med
– volume: 35
  start-page: 7821
  year: 2014
  end-page: 7829
  article-title: ncRuPAR inhibits gastric cancer progression by down‐regulating protease‐activated receptor‐1
  publication-title: Tumour Biol
– volume: 3
  year: 2014
  article-title: Effects of an antisense oligonucleotide inhibitor of C‐reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers
  publication-title: J Am Heart Assoc
– volume: 21
  start-page: 1253
  year: 2015
  end-page: 1261
  article-title: The emerging role of lncRNAs in cancer
  publication-title: Nat Med
– volume: 32
  start-page: 551
  year: 2014
  end-page: 553
  article-title: Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
  publication-title: Nat Biotechnol
– volume: 32
  start-page: 599
  year: 2010
  end-page: 608
  article-title: Non‐coding RNAs: Meet thy masters
  publication-title: Bioessays
– volume: 135
  start-page: 2464
  year: 2015
  end-page: 2474
  article-title: The CASC15 long intergenic noncoding RNA locus is involved in melanoma progression and phenotype switching
  publication-title: J Invest Dermatol
– volume: 100
  start-page: 1037
  year: 2008
  end-page: 1041
  article-title: Discriminatory accuracy from single‐nucleotide polymorphisms in models to predict breast cancer risk
  publication-title: J Natl Cancer Inst
– volume: 37
  start-page: 2379
  year: 2016
  end-page: 2385
  article-title: SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma
  publication-title: Tumour Biol
– volume: 60
  start-page: 1278
  year: 2014
  end-page: 1290
  article-title: Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell‐like property of hepatocellular carcinoma cells by stabilizing NOP2
  publication-title: Hepatology
– volume: 52
  start-page: 1089
  year: 2006
  end-page: 1095
  article-title: APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer
  publication-title: Clin Chem
– volume: 518
  start-page: 409
  year: 2015
  end-page: 412
  article-title: Towards a therapy for Angelman syndrome by targeting a long non‐coding RNA
  publication-title: Nature
– volume: 464
  start-page: 1071
  year: 2010
  end-page: 1076
  article-title: Long non‐coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
  publication-title: Nature
– volume: 9
  start-page: e90008
  year: 2014
  article-title: The has‐miR‐526b binding‐site rs8506G>a polymorphism in the lincRNA‐NR_024015 exon identified by GWASs predispose to non‐cardia gastric cancer risk
  publication-title: PLoS One
– volume: 12
  start-page: 4851
  year: 2006
  end-page: 4858
  article-title: Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma
  publication-title: Clin Cancer Res
– volume: 372
  start-page: 232
  year: 2015
  end-page: 240
  article-title: Factor XI antisense oligonucleotide for prevention of venous thrombosis
  publication-title: N Engl J Med
– volume: 35
  start-page: 8445
  year: 2014
  end-page: 8450
  article-title: Long noncoding RNA HOTAIR can serve as a common molecular marker for lymph node metastasis: a meta‐analysis
  publication-title: Tumour Biol
– volume: 48
  start-page: 219
  year: 2012
  end-page: 230
  article-title: Long noncoding RNAs with snoRNA ends
  publication-title: Mol Cell
– volume: 18
  start-page: 33
  year: 2016
  article-title: Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype‐specific RNAs of triple‐negative breast cancer
  publication-title: Breast Cancer Res
– volume: 29
  start-page: 1810
  year: 2012
  end-page: 1816
  article-title: Long non‐coding RNA MALAT‐1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation
  publication-title: Med Oncol
– volume: 72
  start-page: 113
  year: 2015
  end-page: 118
  article-title: Long non‐coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma
  publication-title: Biomed Pharmacother
– volume: 40
  start-page: 2004
  year: 2012
  end-page: 2012
  article-title: LncRNA pro fi le of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis
  publication-title: Int J Oncol
– volume: 180
  start-page: 2379
  year: 2008
  end-page: 2383
  article-title: Phase I/II marker lesion study of intravesical BC‐819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette‐Guerin
  publication-title: J Urol
– volume: 12
  start-page: 433
  year: 2013
  end-page: 446
  article-title: Targeting long non‐coding RNA to therapeutically upregulate gene expression
  publication-title: Nat Rev Drug Discov
– volume: 13
  start-page: 939
  year: 2007
  end-page: 943
  article-title: The time‐resolved fluorescence‐based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance
  publication-title: Clin Cancer Res
– volume: 12
  start-page: 37
  year: 2012
  article-title: Determination of the differential expression of mitochondrial long non‐coding RNAs as a noninvasive diagnosis of bladder cancer
  publication-title: BMC Urol
– volume: 7
  start-page: 69
  year: 2009
  article-title: Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
  publication-title: J Transl Med
– volume: 31
  start-page: 531
  year: 2016
  end-page: 538
  article-title: Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population
  publication-title: Mutagenesis
– volume: 32
  start-page: 395
  year: 2014
  end-page: 402
  article-title: Long non‐coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial‐mesenchymal transition in colon cance
  publication-title: Oncol Rep
– volume: 35
  start-page: 1751
  year: 2011
  end-page: 1756
  article-title: Expression and function of a large non‐coding RNA gene XIST in human cancer
  publication-title: World J Surg
– volume: 32
  start-page: 104
  year: 2013
  article-title: Association between polymorphisms in long non‐coding RNA PRNCR1 in 8q24 and risk of colorectal cancer
  publication-title: J Exp Clin Cancer Res
– volume: 16
  start-page: 615
  year: 2014
  end-page: 626
  article-title: Long noncoding RNAs as putative biomarkers for prostate cancer detection
  publication-title: J Mol Diagn
– volume: 9
  start-page: e1003569
  year: 2013
  article-title: Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs
  publication-title: PLoS Genet
– volume: 420
  start-page: 563
  year: 2002
  end-page: 573
  article-title: Analysis of the mouse transcriptome based on functional annotation of 60,770 full‐length cDNAs
  publication-title: Nature
– volume: 16
  start-page: 676
  year: 2015
  article-title: Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early‐stage hematopoietic cells
  publication-title: BMC Genomics
– volume: 69
  start-page: 532
  year: 2007
  end-page: 535
  article-title: PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy
  publication-title: Urology
– volume: 9
  start-page: e108237
  year: 2014
  article-title: Long non‐coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC
  publication-title: PLoS One
– volume: 287
  start-page: 21303
  year: 2012
  end-page: 21315
  article-title: Expression of mitochondrial non‐coding RNAs (ncRNAs) is modulated by high risk human papillomavirus (HPV) oncogenes
  publication-title: J Biol Chem
– volume: 53
  start-page: 320
  year: 2000
  end-page: 323
  article-title: The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma
  publication-title: Mol Pathol
– volume: 3
  start-page: e196
  year: 2014
  article-title: De‐repressing LncRNA‐targeted genes to upregulate gene expression: focus on small molecule therapeutics
  publication-title: Mol Ther Nucleic Acids
– volume: 61
  start-page: 69
  year: 2011
  end-page: 90
  article-title: Global cancer statistics
  publication-title: CA Cancer J Clin
– volume: 343
  start-page: 84
  year: 2014
  end-page: 87
  article-title: Genome‐scale CRISPR‐Cas9 knockout screening in human cells
  publication-title: Science
– volume: 59
  start-page: 5975
  year: 1999
  end-page: 5979
  article-title: DD3: a new prostate‐specific gene, highly overexpressed in prostate cancer
  publication-title: Cancer Res
– volume: 6
  start-page: 8579
  year: 2015
  end-page: 8592
  article-title: Prognostic and predictive values of long non‐coding RNA LINC00472 in breast cancer
  publication-title: Oncotarget
– volume: 15
  start-page: 1469
  year: 2014
  end-page: 1480
  article-title: RNA biomarkers associated with metastatic progression in prostate cancer: a multi‐institutional high‐throughput analysis of SChLAP1
  publication-title: Lancet Oncol
– volume: 8
  start-page: 171
  year: 2008
  end-page: 175
  article-title: Promoter hypermethylation of the MEG3 (DLK1/MEG3) imprinted gene in multiple myeloma
  publication-title: Clin Lymphoma Myeloma
– volume: 14
  start-page: 446
  year: 2009
  end-page: 452
  article-title: Non‐coding RNAs and new opportunities for the private sector
  publication-title: Drug Discov Today
– volume: 10
  start-page: 316
  year: 2011
  end-page: 319
  article-title: Non‐coding RNAs: could they be the answer?
  publication-title: Brief Funct Genomics
– volume: 35
  start-page: 1385
  year: 2015
  end-page: 1388
  article-title: A long noncoding RNA, lncRNA‐ATB, is involved in the progression and prognosis of colorectal cancer
  publication-title: Anticancer Res
– volume: 7
  start-page: 761
  year: 2013
  end-page: 766
  article-title: Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis
  publication-title: Mol Med Rep
– volume: 108
  start-page: 2419
  year: 2013
  end-page: 2425
  article-title: Long noncoding RNAs and the genetics of cancer
  publication-title: Br J Cancer
– volume: 43
  start-page: e17
  year: 2015
  article-title: Targeting non‐coding RNAs with the CRISPR/Cas9 system in human cell lines
  publication-title: Nucleic Acids Res
– volume: 75
  start-page: 653
  year: 2015
  end-page: 661
  article-title: A novel urinary long non‐coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy
  publication-title: Prostate
– volume: 13
  start-page: 137
  year: 2015
  article-title: High expression of AFAP1‐AS1 is associated with poor survival and short‐term recurrence in pancreatic ductal adenocarcinoma
  publication-title: J Transl Med
– volume: 34
  start-page: 2697
  year: 2013
  end-page: 2701
  article-title: Decreased expression of long noncoding RNA AC096655.1‐002 in gastric cancer and its clinical significance
  publication-title: Tumour Biol
– volume: 32
  start-page: 357
  year: 2010
  end-page: 367
  article-title: Oral cavity cancer in developed and in developing countries: population‐based incidence
  publication-title: Head Neck
– volume: 39
  start-page: 2119
  year: 2011
  end-page: 2128
  article-title: Large intervening non‐coding RNA HOTAIR is associated with hepatocellular carcinoma progression
  publication-title: J Int Med Res
– volume: 106
  start-page: 9430
  year: 2009
  end-page: 9434
  article-title: Expression of a family of noncoding mitochondrial RNAs distinguishes normal from cancer cells
  publication-title: Proc Natl Acad Sci U S A
– volume: 8
  start-page: 7223
  year: 2015
  end-page: 7228
  article-title: HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis
  publication-title: Int J Clin Exp Pathol
– volume: 32
  start-page: 1655
  year: 2011
  end-page: 1659
  article-title: Human polymorphisms at long non‐coding RNAs (lncRNAs) and association with prostate cancer risk
  publication-title: Carcinogenesis
– volume: 15
  year: 2016
  article-title: Prognostic significance of long non‐coding RNA MALAT‐1 in various human carcinomas: a meta‐analysis
  publication-title: Genet Mol Res
– volume: 1
  start-page: 391
  year: 2011
  end-page: 407
  article-title: The emergence of lncRNAs in cancer biology
  publication-title: Cancer Discov
– volume: 36
  start-page: 1661
  year: 2015
  end-page: 1665
  article-title: A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer
  publication-title: Tumour Biol
– volume: 9
  start-page: e1003368
  year: 2013
  article-title: Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B‐MYB
  publication-title: PLoS Genet
– volume: 19
  start-page: 6520
  year: 2013
  end-page: 6531
  article-title: The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression
  publication-title: Clin Cancer Res
– start-page: 0
  year: 2016
  article-title: Detection of long non‐coding RNAs in human breastmilk extracellular vesicles: Implications for early child development
  publication-title: Epigenetics
– volume: 54
  start-page: 1679
  year: 2011
  end-page: 1689
  article-title: Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans
  publication-title: Hepatology
– volume: 25
  start-page: 135
  year: 2006
  end-page: 141
  article-title: Regulation of apoptosis by a prostate‐specific and prostate cancer‐associated noncoding gene, PCGEM1
  publication-title: DNA Cell Biol
– volume: 477
  start-page: 295
  year: 2011
  end-page: 300
  article-title: lincRNAs act in the circuitry controlling pluripotency and differentiation
  publication-title: Nature
– volume: 46
  start-page: 521
  year: 2015
  end-page: 530
  article-title: Long non‐coding RNA HOTAIR is associated with human cervical cancer progression
  publication-title: Int J Oncol
– volume: 10
  start-page: 626
  year: 2014
  end-page: 628
  article-title: DrugTargetSeqR: a genomics‐ and CRISPR‐Cas9‐based method to analyze drug targets
  publication-title: Nat Chem Biol
– volume: 49
  start-page: 2949
  year: 2013
  end-page: 2959
  article-title: Long non‐coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma‐based biomarker for diagnosing prostate cancer
  publication-title: Eur J Cancer
– volume: 12
  start-page: 1081
  year: 2014
  end-page: 1087
  article-title: The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer
  publication-title: Mol Cancer Res
– volume: 6
  start-page: e1583
  year: 2015
  article-title: Long non‐coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA‐218‐5p
  publication-title: Cell Death Dis
– volume: 43
  start-page: 904
  year: 2011
  end-page: 914
  article-title: Molecular mechanisms of long noncoding RNAs
  publication-title: Mol Cell
– volume: 9
  start-page: e110059
  year: 2014
  article-title: Prognostic value of long non‐coding RNA HOTAIR in various cancers
  publication-title: PLoS One
– volume: 8
  start-page: e1003078
  year: 2012
  article-title: Polyadenylation‐dependent control of long noncoding RNA expression by the poly(A)‐binding protein nuclear 1
  publication-title: PLoS Genet
– volume: 329
  start-page: 689
  year: 2010
  end-page: 693
  article-title: Long noncoding RNA as modular scaffold of histone modification complexes
  publication-title: Science
– volume: 35
  start-page: 757
  year: 2016
  end-page: 770
  article-title: Microarray profiling of bone marrow long non‐coding RNA expression in Chinese pediatric acute myeloid leukemia patients
  publication-title: Oncol Rep
– volume: 19
  start-page: 374
  year: 2012
  end-page: 381
  article-title: Phase 1/2a, dose‐escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC‐819 in patients with unresectable pancreatic cancer
  publication-title: Cancer Gene Ther
– volume: 113
  start-page: 2544
  year: 2016
  end-page: 2549
  article-title: Multiplexed barcoded CRISPR‐Cas9 screening enabled by CombiGEM
  publication-title: Proc Natl Acad Sci U S A
– volume: 472
  start-page: 120
  year: 2011
  end-page: 124
  article-title: A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression
  publication-title: Nature
– volume: 25
  start-page: 566
  year: 2015
  end-page: 569
  article-title: Functions and mechanisms of long noncoding RNAs in ovarian cancer
  publication-title: Int J Gynecol Cancer
– volume: 35
  start-page: 12181
  year: 2014
  end-page: 12188
  article-title: C‐Myc‐activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion
  publication-title: Tumour Biol
– volume: 48
  start-page: 1142
  year: 2016
  end-page: 1150
  article-title: Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer
  publication-title: Nat Genet
– volume: 34
  start-page: 297
  year: 2011
  end-page: 305
  article-title: Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells
  publication-title: Cell Oncol (Dordr)
– volume: 35
  start-page: 10249
  year: 2014
  end-page: 10257
  article-title: Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer
  publication-title: Tumour Biol
– volume: 153
  start-page: 910
  year: 2013
  end-page: 918
  article-title: One‐step generation of mice carrying mutations in multiple genes by CRISPR/Cas‐mediated genome engineering
  publication-title: Cell
– volume: 106
  start-page: 11667
  year: 2009
  end-page: 11672
  article-title: Many human large intergenic noncoding RNAs associate with chromatin‐modifying complexes and affect gene expression
  publication-title: Proc Natl Acad Sci U S A
– volume: 13
  start-page: 3326
  year: 2016
  end-page: 3334
  article-title: Identification of long‐non coding RNA UCA1 as an oncogene in renal cell carcinoma
  publication-title: Mol Med Rep
– volume: 35
  start-page: 11435
  year: 2014
  end-page: 11442
  article-title: Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder
  publication-title: Tumour Biol
– volume: 32
  start-page: 614
  year: 2013
  end-page: 618
  article-title: The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases
  publication-title: Chin J Cancer
– volume: 63
  start-page: 442
  year: 2016
  end-page: 449
  article-title: Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer
  publication-title: Neoplasma
– volume: 2014
  start-page: 404567
  year: 2014
  article-title: Differential expression of long noncoding RNA in primary and recurrent nasopharyngeal carcinoma
  publication-title: Biomed Res Int
– volume: 10
  start-page: 155
  year: 2009
  end-page: 159
  article-title: Long non‐coding RNAs: insights into functions
  publication-title: Nat Rev Genet
– volume: 11
  start-page: e0147236
  year: 2016
  article-title: Expression of the long non‐coding RNA HOTAIR correlates with disease progression in bladder cancer and is contained in bladder cancer patient urinary exosomes
  publication-title: PLoS One
– volume: 56
  start-page: 2231
  year: 2012
  end-page: 2241
  article-title: Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence‐free survival after hepatectomy
  publication-title: Hepatology
– volume: 191
  start-page: 1697
  year: 2014
  end-page: 1702
  article-title: DNA based therapy with diphtheria toxin‐A BC‐819: a phase 2b marker lesion trial in patients with intermediate risk nonmuscle invasive bladder cancer
  publication-title: J Urol
– volume: 470
  start-page: 721
  year: 2016
  end-page: 727
  article-title: Long non‐coding RNA lnc‐MX1‐1 is associated with poor clinical features and promotes cellular proliferation and invasiveness in prostate cancer
  publication-title: Biochem Biophys Res Commun
– volume: 22
  start-page: 99
  year: 2015
  end-page: 109
  article-title: Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence
  publication-title: Endocr Relat Cancer
– volume: 43
  start-page: 621
  year: 2011
  end-page: 629
  article-title: Extensive and coordinated transcription of noncoding RNAs within cell‐cycle promoters
  publication-title: Nat Genet
– ident: e_1_2_9_56_1
  doi: 10.1001/archotol.126.9.1079
– ident: e_1_2_9_42_1
  doi: 10.18632/oncotarget.2691
– ident: e_1_2_9_51_1
  doi: 10.1158/1078-0432.CCR-06-0134
– ident: e_1_2_9_37_1
  doi: 10.1016/j.eururo.2013.09.046
– ident: e_1_2_9_45_1
  doi: 10.1093/nar/gkm863
– ident: e_1_2_9_58_1
  doi: 10.1007/s13277-014-2311-4
– ident: e_1_2_9_105_1
  doi: 10.1007/s13277-014-2863-3
– ident: e_1_2_9_2_1
  doi: 10.1038/nrg2521
– ident: e_1_2_9_30_1
  doi: 10.1016/S0302-2838(03)00201-X
– ident: e_1_2_9_143_1
  doi: 10.1038/mtna.2014.45
– volume-title: Translational research in traumatic brain injury
  year: 2016
  ident: e_1_2_9_119_1
– ident: e_1_2_9_135_1
  doi: 10.1038/cgt.2012.10
– ident: e_1_2_9_128_1
  doi: 10.1371/journal.pone.0090008
– ident: e_1_2_9_111_1
  doi: 10.1186/s13148-015-0141-x
– ident: e_1_2_9_116_1
  doi: 10.1038/jid.2015.200
– ident: e_1_2_9_125_1
  doi: 10.1038/ng.3637
– ident: e_1_2_9_84_1
  doi: 10.3892/or.2014.3186
– ident: e_1_2_9_16_1
  doi: 10.1089/dna.2006.25.135
– ident: e_1_2_9_44_1
  doi: 10.1016/j.jmoldx.2014.06.009
– ident: e_1_2_9_24_1
  doi: 10.1158/2159-8290.CD-11-0209
– ident: e_1_2_9_66_1
  doi: 10.1007/s00268-010-0951-0
– ident: e_1_2_9_103_1
  doi: 10.3816/CLM.2008.n.021
– ident: e_1_2_9_129_1
  doi: 10.1038/pcan.2013.6
– ident: e_1_2_9_121_1
  doi: 10.1038/bjc.2013.233
– ident: e_1_2_9_34_1
  doi: 10.1158/1078-0432.CCR-06-2679
– ident: e_1_2_9_85_1
  doi: 10.1371/journal.pone.0110059
– volume: 35
  start-page: 1385
  year: 2015
  ident: e_1_2_9_90_1
  article-title: A long noncoding RNA, lncRNA‐ATB, is involved in the progression and prognosis of colorectal cancer
  publication-title: Anticancer Res
– ident: e_1_2_9_40_1
  doi: 10.1016/j.eururo.2010.06.039
– volume: 92
  start-page: 384
  year: 2012
  ident: e_1_2_9_52_1
  article-title: [Evaluation of novel gene UCA1 as a tumor biomarker for the detection of bladder cancer]
  publication-title: Zhonghua Yi Xue Za Zhi
– ident: e_1_2_9_133_1
  doi: 10.1016/j.juro.2013.12.011
– ident: e_1_2_9_104_1
  doi: 10.4149/314_150825N45
– ident: e_1_2_9_14_1
  doi: 10.1016/j.molcel.2011.08.018
– ident: e_1_2_9_137_1
  doi: 10.1371/journal.pgen.1003368
– volume: 62
  start-page: 2695
  year: 2002
  ident: e_1_2_9_32_1
  article-title: DD3(PCA3), a very sensitive and specific marker to detect prostate tumors
  publication-title: Cancer Res
– ident: e_1_2_9_67_1
  doi: 10.1007/s13277-014-2526-4
– volume: 19
  start-page: 3187
  year: 2015
  ident: e_1_2_9_72_1
  article-title: High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion
  publication-title: Eur Rev Med Pharmacol Sci
– ident: e_1_2_9_99_1
  doi: 10.1007/s13277-014-2378-y
– ident: e_1_2_9_106_1
  doi: 10.1136/mp.53.6.320
– ident: e_1_2_9_6_1
  doi: 10.1002/bies.200900112
– ident: e_1_2_9_68_1
  doi: 10.1038/cddis.2014.541
– ident: e_1_2_9_102_1
  doi: 10.1002/mc.22215
– ident: e_1_2_9_13_1
  doi: 10.1093/nar/gkt1222
– ident: e_1_2_9_146_1
  doi: 10.1093/nar/gkt464
– ident: e_1_2_9_142_1
  doi: 10.1038/nrd4018
– ident: e_1_2_9_10_1
  doi: 10.1371/journal.pgen.1003078
– ident: e_1_2_9_9_1
  doi: 10.1038/nature01266
– ident: e_1_2_9_86_1
  doi: 10.1136/jclinpath-2015-203275
– ident: e_1_2_9_12_1
  doi: 10.1016/j.molcel.2012.07.033
– ident: e_1_2_9_33_1
  doi: 10.1016/j.eururo.2004.06.004
– ident: e_1_2_9_25_1
  doi: 10.1126/science.1192002
– ident: e_1_2_9_127_1
  doi: 10.1093/mutage/gew018
– ident: e_1_2_9_43_1
  doi: 10.1002/pros.22949
– ident: e_1_2_9_97_1
  doi: 10.1007/s13277-015-3543-7
– ident: e_1_2_9_21_1
  doi: 10.1038/nature10398
– ident: e_1_2_9_73_1
  doi: 10.1186/1471-2407-14-809
– ident: e_1_2_9_38_1
  doi: 10.1016/j.juro.2007.11.038
– ident: e_1_2_9_136_1
  doi: 10.1158/0008-5472.CAN-10-2483
– ident: e_1_2_9_76_1
  doi: 10.18632/oncotarget.7828
– ident: e_1_2_9_141_1
  doi: 10.1038/nature13975
– ident: e_1_2_9_53_1
  doi: 10.3892/mmr.2016.4894
– ident: e_1_2_9_92_1
  doi: 10.1158/0008-5472.CAN-15-3284
– ident: e_1_2_9_120_1
  doi: 10.3109/10408363.2015.1075469
– ident: e_1_2_9_60_1
  doi: 10.3892/or.2015.4415
– ident: e_1_2_9_55_1
  doi: 10.5732/cjc.012.10219
– ident: e_1_2_9_145_1
  doi: 10.1093/nar/gku1198
– ident: e_1_2_9_69_1
  doi: 10.7314/APJCP.2015.16.13.5181
– volume: 15
  year: 2016
  ident: e_1_2_9_75_1
  article-title: Prognostic significance of long non‐coding RNA MALAT‐1 in various human carcinomas: a meta‐analysis
  publication-title: Genet Mol Res
– ident: e_1_2_9_140_1
  doi: 10.1016/j.tips.2013.06.005
– ident: e_1_2_9_152_1
  doi: 10.1073/pnas.1517883113
– ident: e_1_2_9_64_1
  doi: 10.1097/IGC.0000000000000413
– ident: e_1_2_9_94_1
  doi: 10.1186/s13058-016-0690-8
– volume: 40
  start-page: 2004
  year: 2012
  ident: e_1_2_9_118_1
  article-title: LncRNA pro fi le of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis
  publication-title: Int J Oncol
– ident: e_1_2_9_123_1
  doi: 10.1038/pcan.2014.34
– ident: e_1_2_9_134_1
  doi: 10.1016/j.juro.2008.08.006
– ident: e_1_2_9_154_1
  doi: 10.1002/hep.24563
– ident: e_1_2_9_11_1
  doi: 10.1038/nature10887
– ident: e_1_2_9_19_1
  doi: 10.1089/nat.2012.0414
– ident: e_1_2_9_20_1
  doi: 10.1038/nature08975
– volume: 59
  start-page: 5975
  year: 1999
  ident: e_1_2_9_31_1
  article-title: DD3: a new prostate‐specific gene, highly overexpressed in prostate cancer
  publication-title: Cancer Res
– ident: e_1_2_9_80_1
  doi: 10.1177/147323001103900608
– ident: e_1_2_9_149_1
  doi: 10.1126/science.1247005
– ident: e_1_2_9_39_1
  doi: 10.1373/clinchem.2005.063289
– ident: e_1_2_9_98_1
  doi: 10.1007/s13277-013-0821-0
– ident: e_1_2_9_95_1
  doi: 10.3892/mmr.2015.4435
– ident: e_1_2_9_151_1
  doi: 10.1038/nchembio.1551
– ident: e_1_2_9_23_1
  doi: 10.1073/pnas.0904715106
– ident: e_1_2_9_18_1
  doi: 10.1038/ni.3299
– ident: e_1_2_9_89_1
  doi: 10.18632/oncotarget.3287
– ident: e_1_2_9_101_1
  doi: 10.1371/journal.pone.0108237
– ident: e_1_2_9_79_1
  doi: 10.1002/hep.27239
– ident: e_1_2_9_87_1
  doi: 10.1007/s13277-016-4863-y
– ident: e_1_2_9_49_1
  doi: 10.1186/1471-2490-12-37
– ident: e_1_2_9_132_1
  doi: 10.1186/1479-5876-7-69
– ident: e_1_2_9_57_1
  doi: 10.3892/mmr.2012.1254
– ident: e_1_2_9_36_1
  doi: 10.1016/j.juro.2009.01.110
– ident: e_1_2_9_81_1
  doi: 10.1186/1476-4598-13-156
– ident: e_1_2_9_153_1
  doi: 10.1016/j.cell.2013.04.025
– ident: e_1_2_9_15_1
  doi: 10.1016/j.molcel.2012.06.027
– ident: e_1_2_9_138_1
  doi: 10.1056/NEJMoa1405760
– ident: e_1_2_9_4_1
  doi: 10.1016/j.gene.2006.09.028
– ident: e_1_2_9_130_1
  doi: 10.1016/j.eururo.2008.01.060
– ident: e_1_2_9_70_1
  doi: 10.1002/jso.23888
– ident: e_1_2_9_78_1
  doi: 10.1016/j.biopha.2015.04.014
– ident: e_1_2_9_28_1
  doi: 10.1038/nm.3981
– ident: e_1_2_9_35_1
  doi: 10.1016/j.urology.2006.12.014
– ident: e_1_2_9_100_1
  doi: 10.1158/1541-7786.MCR-14-0257
– ident: e_1_2_9_17_1
  doi: 10.1161/CIRCULATIONAHA.114.013303
– ident: e_1_2_9_107_1
  doi: 10.1007/s12032-011-0004-z
– ident: e_1_2_9_27_1
  doi: 10.1016/j.trecan.2015.08.010
– ident: e_1_2_9_83_1
  doi: 10.1002/cam4.220
– ident: e_1_2_9_29_1
  doi: 10.3322/caac.20107
– ident: e_1_2_9_115_1
  doi: 10.1016/j.bbrc.2016.01.056
– ident: e_1_2_9_50_1
  doi: 10.1007/s13277-014-2474-z
– ident: e_1_2_9_71_1
  doi: 10.1186/s12864-015-1881-x
– ident: e_1_2_9_62_1
  doi: 10.1016/j.canlet.2014.12.051
– ident: e_1_2_9_109_1
  doi: 10.1002/hep.25895
– ident: e_1_2_9_148_1
  doi: 10.1038/nbt.2884
– ident: e_1_2_9_108_1
  doi: 10.1245/s10434-011-1581-y
– volume: 32
  start-page: 357
  year: 2010
  ident: e_1_2_9_54_1
  article-title: Oral cavity cancer in developed and in developing countries: population‐based incidence
  publication-title: Head Neck
  doi: 10.1002/hed.21193
– volume: 8
  start-page: 7223
  year: 2015
  ident: e_1_2_9_82_1
  article-title: HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis
  publication-title: Int J Clin Exp Pathol
– ident: e_1_2_9_22_1
  doi: 10.1038/ng.848
– volume: 8
  start-page: 4881
  year: 2015
  ident: e_1_2_9_74_1
  article-title: Downregulation of long noncoding RNA MALAT1 induces epithelial‐to‐mesenchymal transition via the PI3K‐AKT pathway in breast cancer
  publication-title: Int J Clin Exp Pathol
– ident: e_1_2_9_77_1
  doi: 10.1007/s13277-015-4052-4
– ident: e_1_2_9_139_1
  doi: 10.1161/JAHA.114.001084
– ident: e_1_2_9_147_1
  doi: 10.4161/rna.29624
– ident: e_1_2_9_46_1
  doi: 10.1073/pnas.0903086106
– ident: e_1_2_9_117_1
  doi: 10.1530/ERC-14-0457
– ident: e_1_2_9_126_1
  doi: 10.1186/1756-9966-32-104
– ident: e_1_2_9_48_1
  doi: 10.1007/s13402-011-0018-8
– ident: e_1_2_9_93_1
  doi: 10.1111/apm.12480
– ident: e_1_2_9_3_1
  doi: 10.1371/journal.pgen.1003569
– ident: e_1_2_9_91_1
  doi: 10.1016/S1470-2045(14)71113-1
– ident: e_1_2_9_131_1
  doi: 10.1093/jnci/djn180
– start-page: 0
  year: 2016
  ident: e_1_2_9_144_1
  article-title: Detection of long non‐coding RNAs in human breastmilk extracellular vesicles: Implications for early child development
  publication-title: Epigenetics
– ident: e_1_2_9_7_1
  doi: 10.1073/pnas.0903103106
– ident: e_1_2_9_150_1
  doi: 10.1126/science.1246981
– ident: e_1_2_9_59_1
  doi: 10.1371/journal.pone.0147236
– ident: e_1_2_9_96_1
  doi: 10.1007/s13277-014-2042-6
– ident: e_1_2_9_113_1
  doi: 10.1007/s13277-014-2765-4
– ident: e_1_2_9_41_1
  doi: 10.1016/j.ejca.2013.04.026
– ident: e_1_2_9_124_1
  doi: 10.1111/j.1349-7006.2010.01737.x
– ident: e_1_2_9_61_1
  doi: 10.1002/stem.1989
– ident: e_1_2_9_114_1
  doi: 10.1155/2014/404567
– ident: e_1_2_9_5_1
  doi: 10.1016/j.drudis.2009.01.008
– volume: 8
  start-page: 7887
  year: 2015
  ident: e_1_2_9_65_1
  article-title: Combined identification of long non‐coding RNA XIST and HIF1A‐AS1 in serum as an effective screening for non‐small cell lung cancer
  publication-title: Int J Clin Exp Pathol
– ident: e_1_2_9_122_1
  doi: 10.1093/carcin/bgr187
– ident: e_1_2_9_112_1
  doi: 10.3892/ijo.2014.2758
– ident: e_1_2_9_88_1
  doi: 10.1186/s12967-015-0490-4
– ident: e_1_2_9_26_1
  doi: 10.1038/nature09819
– ident: e_1_2_9_47_1
  doi: 10.1074/jbc.M111.326694
– ident: e_1_2_9_63_1
  doi: 10.1158/1078-0432.CCR-13-0877
– ident: e_1_2_9_8_1
  doi: 10.1093/bfgp/elq029
– ident: e_1_2_9_110_1
  doi: 10.1007/s13277-014-2344-8
SSID ssj0011504
Score 2.6642673
SecondaryResourceType review_article
Snippet Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non‐coding RNAs...
Because of high specificity and easy detection in the tissues, serum, plasma, urine and saliva, interest in exploring the potential of long non-coding RNAs...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1955
SubjectTerms Antigens, Neoplasm - genetics
biomarker
Biomarkers
Biomarkers, Tumor - genetics
Cancer
diagnosis
Gene Expression Regulation, Neoplastic
Genes
Humans
long non‐coding RNA
Medical research
Neoplasms - diagnosis
Neoplasms - genetics
Neoplasms - pathology
Polymorphism, Single Nucleotide
Prognosis
Prostate cancer
Rana
Risk Factors
RNA, Long Noncoding - genetics
therapy
Title Potential of long non‐coding RNAs in cancer patients: From biomarkers to therapeutic targets
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.30546
https://www.ncbi.nlm.nih.gov/pubmed/27925173
https://www.proquest.com/docview/1876731899
https://www.proquest.com/docview/1846722197
https://www.proquest.com/docview/1881761901
Volume 140
WOSCitedRecordID wos000399313000002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1097-0215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011504
  issn: 0020-7136
  databaseCode: DRFUL
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT-MwEB5BWa248Fhe5SWz2gOX0CR1YgdOCKgAsVVVLVJPRI5jo6KSoKTlzE_gN_JLGCdpAO1DSHuLlIk09nzjGccznwF-eF4suR0Li_paWpgRUyuwRWBxwWLckGDUUbK4bIJ1u3wwCHozcDTthSn5IeofbsYzivXaOLiI8tYbaejwTh4gWKk_C3Mu4tZrwNxpv3N9VR8iYK5TkTDbFu7F_CmxkO226o8_hqPfcsyPKWsRczqL_6XtEixUqSY5LrGxDDMq-QZff1aH6Stw00vHplYIZVJNRmlyS5I0eXl6lqkJaKTfPc7JMCHSACMjFQNrfkg6WXpPTN--Ke3JcjJOybs2LlIWl-ercN05-3VyblXXLVgSbeRbcaAx2keuaTdVksW0rQXTyhDkUKptJnwaae0qGTPPkY7pwZYY9yKKOYdwRNBegwaqqTaAcASA5nHMFWtTJnjg8ciR1ENYUIFWacL-dNZDWXGRmysxRmHJouyGOF9hMV9N-F6LPpQEHH8S2p6aLqx8MA8dHBTDJSsImrBXv0bvMUciIlHpxMhgoHBx1Wb_kuGO-dljO01YL2FRa2LoFz2HtXFAhfX_rmJ4cXlSPGx-XnQL5l2TRRT1ldvQGGcTtQNf5ON4mGe7MMsGfLcC_Su5EgKn
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3BTtwwEB1RqAoXaKHAAm1N1QOXdJOsEzuIC4KuoF1WCIHEicjr2GgRJChZOPMJfCNfwkySTUGUqlJvkTKRxp43nok98wzwLQgSLd1EOTy02sGMmDuRqyJHKpHgDwlGHaPLyyZEvy9PT6PDCdga98JU_BDNhht5Rrlek4PThnT7N2vo8EJ_R7Ty8A1McYQR4ntq96h70mtOETDZqVmYXQd_xsIxs5Drt5uPn8ejF0nm85y1DDrduf9T9z3M1skm267Q8QEmTDoP7w7q4_QFODvMRlQthDKZZZdZes7SLH24u9cZhTR21N8u2DBlmqCRs5qDtdhk3Ty7YtS5T8U9ecFGGXvSyMWq8vLiI5x0fxzv7Dn1hQuORiuFThJZjPcDnxpOjRYJ71glrCGKHM6tK1TIB9b6Rici8LRHXdgaI9-AY9ahPBV1FmES1TTLwCRCwMokkUZ0uFAyCuTA0zxAYHCFZmnBxnjaY12zkdOlGJdxxaPsxzhfcTlfLfjaiF5XFBx_Elob2y6uvbCIPRyUwEUrilqw3rxG_6FDEZWa7IZkMFT4uG6Lv8lIj7Z7XK8FSxUuGk2IgDHwRAcHVJr_dRXj_Z875cPKv4t-gem944Ne3Nvv_1qFGZ9yirLacg0mR_mN-QRv9e1oWOSfa-w_AhuJBa8
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fT9RAEJ_AYQgv-AfEE9TV8OBLpe1tu1vjCwEbUbxciCQ82eztH3IEW9IePPsR-Ix8EmbaXpWAhoS3Jp1NZndmdmZ3Z34DsBlFRkvfKI_HTnsYEXMv8VXiSSUMHkjQ61hdN5sQw6E8OkpGc_BpVgvT4EN0F25kGfV-TQZuz4zb-oMaOjnRH1BbeTwPC5yayPRgYfcgPdzvXhEw2GlRmH0PD2PxDFnID7e6wTf90a0g82bMWjud9PHD2H0Cy22wybYb7XgKczZ_Bovf2-f0Ffg5KqaULYQ0hWOnRX7M8iK_-n2pC3Jp7GC4XbFJzjSpRslaDNbqI0vL4hejyn1K7ikrNi3YX4VcrEkvr1bhMP38Y-eL1zZc8DRKKfZM4tDfj0MqOLVaGD5wSjhLEDmcO1-omI-dC602Igp0QFXYGj3fmGPUoQKVDJ5DD9m0L4BJVAEnjZFWDLhQMonkONA8QsXgCsXSh_ezZc90i0ZOTTFOswZHOcxwvbJ6vfrwriM9ayA47iLamMkua62wygKclMBNK0n68Lb7jfZDjyIqt8U50aCrCHHfFv-jkQFd9_hBH9Yaveg4IQDGKBADnFAt_n-zmO193ak_Xt6f9A0sjnbTbH9v-G0dlkIKKepkyw3oTctz-woe6YvppCpft6p_DZ3_BSo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Potential+of+long+non%E2%80%90coding+RNAs+in+cancer+patients%3A+From+biomarkers+to+therapeutic+targets&rft.jtitle=International+journal+of+cancer&rft.au=Chandra+Gupta%2C+Subash&rft.au=Nandan+Tripathi%2C+Yashoda&rft.date=2017-05-01&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=140&rft.issue=9&rft.spage=1955&rft.epage=1967&rft_id=info:doi/10.1002%2Fijc.30546&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_ijc_30546
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon